StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.18+0.11 (+3.58%)

Close on Nov 17, 2026Market cap $792.42MP/E –Yield –

Ardelyx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Ardelyx's price to sales ratio was 1.7× on Nov 11, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 1.7× to 60.9×, with a median of 8.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×−1.8
2025Dec 31, 20253.6×−1.2
2024Dec 31, 20244.8×−6.0
2023Dec 29, 202310.7×−48.6
2022Dec 30, 202259.3×+48.5
2021Dec 31, 202110.8×−62.1
2020Dec 31, 202072.9×−8.7
2019Apr 30, 201981.5×+79.0
2018Dec 31, 20182.5×−6.2
2016Apr 29, 20168.7×−6.8
2015Dec 31, 201515.5×+5.2
2014Dec 31, 201410.3×–

More Ardelyx figures

See a number that looks wrong?